ZisNews - Breaking News & Updates

DAnish pharmaceutic john major Novo Nordisk on th launched its once-weekly base insulin injectant, Awiqli, in India for the treatment of diabetes in adults, marking the country's entry as the seventh market to introduce the therapy.The company said Awiqli is designed for people with Type 1 and Type 2 diabetes mellitus and replaces the need for a daily basal insulin injection with a once-a-week dose. This reduces the annual number of injections from 365 to just 52."It is a modern therapy, and we (India) are the seventh country to launch (the injection)," Novo Nordisk India Managing Director, Vikrant Shrotriya told PTI, adding that the injection will be introduced in two pens - 700 units and 2,100 units, with a per unit cost of ₹3.73.Also Read | Novo Nordisk cuts Ozempic price in India amid generics onslaughtWith the reduction of the number of injections required for diabetic patients, the company stated that the barriers to needing insulin will be reduced.Shrotriya noted that in usual therapies patients with diabetes normally will have to take insulin injection every day, which leads to people actually denying insulin as "they think that they have to take every day and they have to take lifelong".But with Awiqli, that barrier is reduced, and patients get greater control.Also Read | Doctor explains how climate change, rising temperatures may influence your diabetes patterns"We believe Awiqli will reduce the psychological and physical barriers to insulin initiation, and ultimately help more people achieve better control and a better quality of life," the managing director added.The injection will be available across the country through 4,5000 distributors.(With inputs from PTI)

Global News Perspectives

In today's interconnected world, staying informed about global events is more important than ever. ZisNews provides news coverage from multiple countries, allowing you to compare how different regions report on the same stories. This unique approach helps you gain a broader and more balanced understanding of international affairs. Whether it's politics, business, technology, or cultural trends, ZisNews ensures that you get a well-rounded perspective rather than a one-sided view. Expand your knowledge and see how global narratives unfold from different angles.

Customizable News Feed

At ZisNews, we understand that not every news story interests everyone. That's why we offer a customizable news feed, allowing you to control what you see. By adding keywords, you can filter out unwanted news, blocking articles that contain specific words in their titles or descriptions. This feature enables you to create a personalized experience where you only receive content that aligns with your interests. Register today to take full advantage of this functionality and enjoy a distraction-free news feed.

Like or Comment on News

Stay engaged with the news by interacting with stories that matter to you. Like or dislike articles based on your opinion, and share your thoughts in the comments section. Join discussions, see what others are saying, and be a part of an informed community that values meaningful conversations.

Download the Android App

For a seamless news experience, download the ZisNews Android app. Get instant notifications based on your selected categories and stay updated on breaking news. The app also allows you to block unwanted news, ensuring that you only receive content that aligns with your preferences. Stay connected anytime, anywhere.

Diverse News Categories

With ZisNews, you can explore a wide range of topics, ensuring that you never miss important developments. From Technology and Science to Sports, Politics, and Entertainment, we bring you the latest updates from the world's most trusted sources. Whether you are interested in groundbreaking scientific discoveries, tech innovations, or major sports events, our platform keeps you updated in real-time. Our carefully curated news selection helps you stay ahead, providing accurate and relevant stories tailored to diverse interests.

India gets Novo Nordisk's once-weekly insulin injection Awiqli for adults with diabetes

Global News Perspectives

Customizable News Feed

Like or Comment on News

Download the Android App

Diverse News Categories

Category News

Country News